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Abstract
Background: Patellofemoral pain syndrome (PFP) is a common musculoskeletal condition that has a tendency to
become chronic and problematic in a proportion of affected individuals. The objective of this study was to identify
prognostic factors that may have clinical utility in predicting poor outcome on measures of pain and function in
individuals with PFP.
Methods: A prospective follow-up study was conducted of 179 participants in a randomised clinical trial. Nine
baseline factors (age, gender, body mass index, arch height, duration of knee pain, worst pain visual analogue
scale, Kujala Patellofemoral Score (KPS), functional index questionnaire (FIQ), step down repetitions) were
investigated for their prognostic ability on outcome assessed at six, 12 and 52 weeks (worst pain, KPS and FIQ).
Factors with significant univariate associations were entered into multivariate linear regression models to identify a
group of factors independently associated with poor outcome.
Results: Long symptom duration was the most consistent predictor of poor outcome over 52 weeks rated on the
KPS and the FIQ (b-0.07, 95% confidence interval -0.1 to -0.03, p < 0.000; and -0.02, -0.03 to -0.01, p < 0.000,
respectively). Worse KPS at baseline was predictive of outcome at six, 12 and 52 weeks. Gender, body mass index
and arch height were generally not associated with outcome (univariate analysis), while age, worst pain, FIQ and
step downs were excluded during multivariate analyses.
Conclusions: Patients presenting with PFP of long duration who score worse on the KPS have a poorer prognosis,
irrespective of age, gender and morphometry. These results suggest that strategies aimed at preventing chronicity
of more severe PFP may optimise prognosis.
Background
Patellofemoral pain syndrome (PFP), or idiopathic pain
arising from the anterior knee, is one of the most com-
mon musculoskeletal conditions affecting young active
adults [1-6], and has a tendency to persist to some
degree in a substantial proportion of affected individuals
[7]. Prospective longitudinal studies have demonstrated
the propensity towards chronicity of PFP in active popu-
lations (adolescent females [8], military personnel [9]).
Identification of people who are likely to have persistent
PFP will enable clinicians to provide patients with a
more accurate picture of their prognosis [10], thereby
facilitating negotiation of more realistic expectations of
outcome and long term management [11].
Prognostic factors, such as demographic, diagnostic or
co-morbid characteristics of an individual measured at
baseline, are generally used to identify those with a greater
likelihood of a poor outcome over time [12,13]. Several
attempts have been made to determine prognostic indica-
tors of outcome in PFP [14-17]; however, due to methodo-
logical issues it is difficult to draw valid conclusions
applicable to the clinical context. For example, treatment
was not accounted for in the design and analysis of any of
these studies, thereby making it difficult to discern if it
was the treatment or the derived prognostic factors that
was responsible for the outcome. One study did not
exclude volunteers with PFP of traumatic onset [14], while
other studies utilised outcome measures not specific to
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clinic (e.g. laboratory-based tests [14]). Notwithstanding
these shortcomings, the individual studies identified older
age, greater height, and longer duration of symptoms as
some prognostic factors, but none of these variables were
found consistently across multiple studies.
On the basis of this, further high-quality research into
the predictive ability of variables such as age, gender, body
mass index (BMI), foot posture, duration of symptoms,
pain severity and functional limitation is warranted. A sys-
tematic review found older age, higher baseline pain sever-
ity, longer pain duration and higher baseline disability to
be consistent prognostic factors in musculoskeletal condi-
tions [11]. The well-documented higher prevalence of PFP
in females raises the question as to whether gender also
influences prognosis [1,18]. Although a previous study
failed to identify BMI as a significant prognostic factor
[17], baseline data from a recent randomised clinical trial
[19] revealed a trend towards the higher end of normal for
healthy body weight. As BMI is modifiable through weight
control, its identification as a prognostic factor would pro-
vide another intervention by which to improve the prog-
nosis of PFP sufferers, and hence should be further
investigated. Despite a postulated relationship between
PFP and foot posture [20,21], the role of foot posture as a
prognostic indicator has not been well investigated. Only
one of the four previous prognostic studies investigated
foot posture [17] using a measure of ankle hyperpronation
during a bilateral squat (none 0-3°; mild 4-6°; clear > 6°).
However, the reliability and validity of this measure was
not reported. Considering the recent development of a
reliable method of measuring the foot [22], the prognostic
ability of foot posture in PFP should be investigated
further.
The tendency for PFP to become persistent and pro-
blematic in some individuals has long term implications
for participation in daily and work tasks as well as phy-
sical activity [7]. The current literature provides only
preliminary data on which to determine the prognosis
of sufferers of this condition. In order to address this
shortfall, baseline measures of such variables as age,
gender, BMI, foot posture, duration of symptoms, pain
severity and functional limitation were evaluated for
their influence on short and long term outcome. The
objective of this study was to determine whether there
are reliable factors with high clinical utility that are pre-
dictive of poor short term (six and 12 weeks) and longer
term (52 weeks) outcome on clinical measures of pain
and function in individuals with PFP.
Methods
Study design
A prospective follow-up study was conducted post-hoc
using data from a previously reported single-blind,
single centre, 12-month randomised clinical trial [19,23].
179 participants with PFP were randomly assigned to a
six-week treatment program of multimodal physiother-
apy consisting of patellofemoral joint mobilisation,
patellar taping, quadriceps muscle retraining and educa-
tion (n = 45), prefabricated foot orthoses (n = 46), flat
shoe inserts (n = 44), or foot orthoses plus physiother-
apy (n = 44). Ethical approval was granted by The Uni-
versity of Queensland’s medical research ethics
committee, and all participants provided written
informed consent.
Participants
Participants were recruited from the greater Brisbane,
Gold Coast and Toowoomba regions of Queensland,
Australia between May 2004 and May 2006 through
paid advertisements in print media, radio and television
media, noticeboards, and referrals from practitioners.
Volunteers underwent a clinical examination (including
interview and physical examination) by an experienced
physiotherapist, and were included if they fulfilled the
following criteria [24]: (i) age 18 to 40 years; (ii) insi-
dious onset of anterior knee or retropatellar pain greater
than six weeks duration andp r o v o k e db ya tl e a s tt w o
of: prolonged sitting or kneeling, squatting, running,
hopping, or stair walking; (iii) tenderness on patellar
palpation, or pain with step down or double leg squat;
and (iv) pain over the previous week of at least 30 milli-
metres on a 100 millimetre visual analogue scale (VAS).
Exclusion criteria were concomitant injury or pain from
the hip or lumbar spine or other knee structures; pre-
vious knee surgery; patellofemoral instability; knee joint
effusion; any foot condition that precluded use of foot
orthoses; allergy to strapping tape; physiotherapy or foot
orthoses within the previous year; or use of anti-inflam-
matory medication. Baseline characteristics of the parti-
cipants are presented in Table 1.
Predictor factors and outcome assessment
A blinded assessor recorded potential prognostic indica-
tors at baseline prior to randomisation. Nine factors
were selected for investigation with respect to their
prognostic ability. Participant characteristics included
age, gender, BMI and weight bearing arch height, which
was measured as the distance from the standing surface
to the dorsal surface of the foot at a point halfway along
the length of the foot [22]. PFP variables were repre-
sented by duration of knee pain and baseline scores of
pain and function. Worst pain over the preceding week
was rated on a 100 millimetre VAS, with the descriptors
‘no pain’ at the zero millimetre mark and ‘worst pain
imaginable’ anchoring the 100 millimetre end [25]. The
Kujala Patellofemoral Score (KPS) consists of 13 items
with discrete categories related to limp, weight bearing,
walking, stairs, squatting, running, jumping, prolonged
sitting with flexed knees, pain, swelling, painful patellar
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[26]. Participants selected one response to each item
that best described their knee condition, and individual
i t e m sw e r es u m m e dt op r o v i d eaf i n a ls c o r ew h e r ez e r o
represented maximal disability and 100 represented no
disability. The functional index questionnaire (FIQ)
comprises eight questions regarding aggravating activ-
ities for PFP [27]. Participants rated their degree of diffi-
culty performing each activity, with the sum of scores
providing an overall score of disability ranging from
zero (maximal disability) to 16 (no disability). Pain-free
step down repetitions were performed on a 25 centi-
metre step in an order that continually loaded the nomi-
nated lower limb [24]. A metronome set at 96 beats per
minute was used to standardise the rate of testing. The
repetition number on which the first onset of pain
occurred, or the first increase in pain for participants
who had a constant background ache prior to testing,
was recorded, up to a maximum of 25 repetitions.
The blinded assessor measured outcome at six, 12 and
52 weeks by way of worst pain VAS, KPS and FIQ,
which have established reliability and validity in PFP
[25,27-30].
Statistical analysis
Statistical analysis was carried out using SPSS software
(Version 15.0). The first stage of the analysis used uni-
variate linear regression to investigate associations
between each single potential prognostic factor and each
outcome measure at six, 12 and 52 weeks. The baseline
value of the outcome measure and the treatment group
that participants were randomly assigned to within the
randomised clinical trial were included as covariates in
each analysis. Interactions between treatment group and
each potential prognostic factor were evaluated to deter-
mine whether there existed any differences in prognostic
variables between groups. For these interaction analyses,
the flat insert group served as the reference group. This
was done on the basis that flat inserts served as a con-
trol arm of the randomised clinical trial, as was borne
out by the results thereof. A significance level of p ≤ 0.1
rather than the conventional level of p <0 . 0 5w a s
selected to ensure that the univariate analyses were suf-
ficiently sensitive to identify potential prognostic factors
for entry in the model. This is consistent with the work
of others in prognostic studies of musculoskeletal condi-
tions [10,31].
For the second stage, all potential prognostic factors that
showed significant associations on univariate analyses were
entered into a stepwise multivariate linear regression with
backward elimination (p ≤ 0.10) in order to identify a
group of factors that were independently associated with
poor outcome on each outcome measure at six, 12 and 52
weeks. This was conducted firstly without interactions,
and then with significant interactions retained in the
model. For the final multivariate models, the significance
was set at 0.01 to minimise the results being adversely
influenced by the likelihood of increased risk of Type I
error associated with multiple analyses. The strength of
the predictive ability of identified factors was determined
with unstandardised regression coefficients (b)a n dt h e i r
95% confidence intervals, while the predictive power of
each final model was given by calculation of the percen-
tage of explained variance (adjusted R
2).
Results
Prognostic indicators of outcome at six weeks
Univariate linear regression revealed that duration of
knee pain, baseline scores of worst pain, FIQ and KPS,
and number of pain-free step down repetitions were sig-
nificantly associated with six-week KPS (additional file
1: Table S1). Of these, longer duration of knee pain (b-
0.04, 95% confidence interval -0.07 to -0.01, p =0 . 0 0 4 )
and lower baseline KPS (0.48, 0.31 to 0.65, p <0 . 0 0 0 )
remained significantly associated with a lower six-week
KPS in the multivariate model, which explained 40.1%
of the total variance.
All potential prognostic indicators except BMI had
significant univariate associations with six-week FIQ.
Longer duration (-0.01, -0.02 to 0, p = 0.006) and lower
baseline FIQ (0.56, 0.36 to 0.77, p < 0.000) remained sig-
nificantly associated with lower six-week FIQ on multi-
variate analysis, which explained 38.6% of the total
variance.
Age, duration, and baseline measures of worst pain,
FIQ, KPS and pain-free step downs had significant
Table 1 Baseline participant characteristics for the study
cohort (n = 179); values are mean (SD) unless otherwise
stated.
Characteristics
Age (years) 29.3 (5.8)
Number (%) of females 100 (55.9)
Height (cm) 173 (9.5)
Weight (kg) 74.7 (18.6)
Body Mass Index (kg/m
2) 24.8 (5.1)
Physical activity* (kcal/kg) 41 (7.3)
Bilateral knee pain: Number (%) 102 (57)
Duration of knee pain (months): Median (IQR) 28 (12-84)
Usual pain^ 36.3 (16.6)
Worst pain^ 60.5 (15.9)
Kujala Patellofemoral Score
† 71.5 (9.8)
Functional index questionnaire
‡ 9.8 (2.1)
* Physical activity over the previous week questionnaire, total energy
expended per day.
^ Pain measured on a 100 mm visual analogue scale; 0 mm = no pain, 100
mm = worst pain imaginable.
† 0-100 points; 100 = no disability.
‡ 0-16 points; 16 = no disability.
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multivariate analysis showed that higher worst pain at
baseline retained a significant association with a
higher six-week worst pain (0.42, 0.16 to 0.69, p =0 . 0 0 2 ;
R
2 = 23%).
Significant univariate interactions between treatment
group and age for all three outcome measures, as well
as between treatment group and arch height for FIQ,
did not significantly alter the predictor factors on out-
come when included in the multivariate models.
Prognostic indicators of outcome at 12 weeks
Baseline worst pain, KPS and pain-free step downs had
significant univariate associations with 12-week KPS
(additional file 1: Table S2). On multivariate analysis,
lower baseline KPS retained a significant association
with lower 12-week KPS (0.45, 0.27 to 0.64, p < 0.000).
The interaction between treatment group and baseline
FIQ was not significant in the final model, with its
inclusion only increasing the percentage of explained
total variance from 23.2% to 28%, with baseline KPS
remaining a significant predictor (0.43, 0.18 to 0.68, p =
0.001).
Univariate analyses found duration and baseline scores
for worst pain and KPS to be significantly associated
with 12-week FIQ. In the multivariate model, which
explained 22% of the total variance, lower baseline KPS
remained significantly associated with lower FIQ at 12
weeks (0.12, 0.07 to 0.16, p < 0.000). The inclusion in
the model of significant univariate interactions between
treatment group and baseline FIQ, as well as treatment
group and pain-free step downs, increased the explained
variance to 34.7%; however KPS was no longer a signifi-
cant predictor (0.08, 0.01 to 0.14, p = 0.019), nor were
there any other significant associations.
On univariate analyses, age, duration, baseline scores
of worst pain, FIQ and KPS, and number of pain-free
step downs were significantly associated with 12-week
worst pain. Multivariate analysis revealed no prognostic
indicators of 12-week worst pain with or without the
inclusion of the treatment group by duration interaction,
which was significant on univariate analysis.
Prognostic indicators of outcome at 52 weeks
Duration as well as worst pain and KPS at baseline had
significant univariate associations with 52-week KPS
(additional file 1: Table S3). Longer duration (-0.07, -0.1
to -0.03, p < 0.000) and lower baseline KPS (0.33, 0.13
to 0.53, p = 0.002) maintained this significant associa-
tion in the multivariate model, which explained 29.5% of
the total variance. When interactions between treatment
group and duration as well as treatment group and FIQ
were included, the association between KPS at baseline
and 52 weeks remained significant (0.4, 0.17 to 0.63,
p = 0.001), but the association between duration and
52-week KPS was not statistically significant (-0.11,
-0.19 to -0.02, p = 0.013). The final model with interac-
tions included explained 49.7% of the total variance.
Age, duration, baseline scores of worst pain, FIQ and
KPS, and pain-free step downs were all significantly
associated with 52-week FIQ on univariate analyses.
Multivariate analysis revealed that long duration was
significantly associated with low 52-week FIQ (-0.02,
-0.03 to -0.01, p < 0.000), with the final model explain-
ing 26.6% of the total variance. This did not change
with the inclusion of the treatment group by age
interaction.
On univariate analyses, duration and baseline scores of
worst pain and KPS had significant associations with 52-
week worst pain; however were not significant in the
multivariate model (adjusted R
2 = 5.4%).
Discussion
Multivariate regression analyses revealed that the two
most consistent predictors of poor outcome in indivi-
duals with PFP over a 12-month period were a long
duration of knee pain and a low baseline KPS. At six
weeks, long pain duration was predictive of poor out-
come on two of the three outcome measures (KPS and
FIQ), while baseline scores of each measure that indi-
cated greater severity of the condition not surprisingly
predicted poor outcome on their respective measures.
KPS was also found to be the sole prognostic indicator
at 12 weeks when outcome was measured with the same
questionnaire and the FIQ. Long pain duration was also
predictive of poor outcome at 52 weeks when measured
on the KPS and FIQ, while low KPS at baseline was pre-
dictive of poor 52-week outcome on the KPS.
Findings of our study are consistent with those of
Mallen et al [11], whose systematic review of generic
musculoskeletal pain found that longer pain duration
and higher baseline disability were consistent prognostic
indicators in musculoskeletal conditions. However,
u n l i k eM a l l e ne ta l[ 1 1 ]w ed i dn o tf i n da g et ob ep r e -
dictive of outcome in our PFP cohort. This may be due
to the difference in age ranges between studies. While
our cohort was restricted to 18 to 40 years of age, the
majority of studies in their systematic review included a
greater age range of participants; frequently aged from
18 to at least 65 years [11]. It is also plausible that age
is a condition-specific prognostic factor.
This study also confirms previous findings with respect
to factors that are not predictive of outcome in PFP. Based
on findings of ours and previous studies [15-17], gender
does not appear to be a prognostic factor for PFP. The
lack of association that we found between BMI and out-
come is consistent with findings in both PFP [17] and gen-
eral knee complaints [32], and implies that modifying or
controlling BMI in those with PFP is unlikely to change
their prognosis. One consideration is that, despite the
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PFP group was not classified as overweight (Table 1).
Hence, further studies may need to consider subgroup
analysis based on BMI classification.
This study investigated the prognostic role of foot
posture based on the long-hypothesised relationship
between foot pronation, biomechanical function of the
patellofemoral joint, and the genesis of PFP [20]. While
this has been explored in a previous prognostic study
[17], ours is the first to utilise a reliable measure [22]. A
static measure of weight bearing arch height was
selected as a representative measure of foot posture, on
the basis that it is reliable and valid, well correlated with
dynamic foot function, and is simple and efficient to
obtain in a clinical setting [33,34]. Our finding that foot
posture was not predictive of outcome in PFP is consis-
tent with previous studies that failed to identify any
other lower limb biomechanical measures as prognostic
factors [15-17], although further research to confirm
this for biomechanical measures other than foot posture
is warranted.
While this study has identified pain duration and KPS
as prognostic indicators, there may be other factors of a
physical or psychological nature that are stronger pre-
dictors of outcome for PFP. Our findings provide guide-
lines as to physical factors worthy of inclusion in and
exclusion from future prognostic studies. Psychological
prognostic factors identified for other chronic musculos-
keletal conditions such as anxiety and depression [11],
and coping strategies such as catastrophising [35],
require investigation in a PFP cohort.
Given that persistent knee pain has been implicated as
a precursor to osteoarthritis [36,37], the findings of this
study are of substantial individual and public health
importance. Our results suggest that, in order to opti-
mise prognosis of individuals with PFP, it is best to
attempt to prevent chronicity and minimise the severity
of the condition. This may be achieved through educa-
tion regarding the importance of early intervention to
minimise duration. Intervention should aim to improve
scores on the KPS, worst pain VAS and FIQ as quickly
as possible, utilising modalities such as foot orthoses
and multimodal physiotherapy that have the best evi-
dence for efficacy in PFP [19,24], as well as advice to
avoid pain-provoking activities while maintaining an
otherwise physically active lifestyle. Future clinical trials
should also investigate the ability of other pain-relieving
modalities to reduce pain more rapidly, such as electro-
therapy, transcutaneous electrical nerve stimulation,
analgesics, anti-inflammatory medication and acupunc-
ture. Furthermore, KPS, worst pain VAS and FIQ scores
that constitute low versus high severity need to be
determined to facilitate more precise clinical application.
The inclusion of significant interactions between treat-
ment group and potential prognostic variables in the
multivariate model largely did not affect conclusions
drawn from the final model, although there was gener-
ally an increase in the percentage of total variability
explained by the model. This indicates that the prognos-
tic factors identified for the entire cohort were not mod-
ified by any of the interventions.
Compared to previous prognostic studies, our study
sought to control a number of factors that could com-
promise the external validity of its findings. Firstly, we
have attempted to control for possible differential treat-
ment effects and analyse outcome independent of inter-
vention received. Because the previous four studies
assigned the same standardised treatment program to all
participants, their results look at the predictive ability of
particular variables when treated with a standardised
program [14-17]. In contrast, participants in the current
s t u d yw e r er a n d o m l ya s s i g n e dt oo n eo ff o u rd i f f e r e n t
interventions, and treatment effects were accounted for
in analyses through inclusion of treatment as a covari-
ate. Secondly, we utilised outcome measures that have
been previously established as reliable and valid for PFP.
Thirdly, our methodology addresses a shortfall of pre-
vious musculoskeletal prognostic studies identified by
Mallen et al [11], in that the measures investigated for
potential predictive ability and those used to measure
outcome have high clinical utility and are easily applied
in a clinical setting.
Conclusions
This study has identified simple, clinically appropriate
and reliable condition-specific measures that are predic-
tive of poor outcome in individuals with PFP. Patients
presenting with PFP of long duration and a low KPS
should be flagged as potentially having a poorer out-
come over time, irrespective of their age, gender and
morphometry. These findings suggest that attempting to
prevent PFP chronicity by using efficacious interventions
e a r l ya f t e rt h eo n s e to fs y m p t o m sm a yo p t i m i s ep r o g -
nosis for this patient group, which may have important
implications for prevention of potential sequelae of long
term pain and disability.
Additional file 1: Results of six, 12 and 52-week prognostic
analyses. Table S1. Prognostic indicators of outcome at six weeks (n =
164^) (adjusted for treatment group). Table S2. Prognostic indicators of
outcome at 12 weeks (n = 161^) (adjusted for treatment group). Table
S3. Prognostic indicators of outcome at 52 weeks (n = 170, 145, 171,
respectively^) (adjusted for treatment group).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2474-11-
11-S1.DOC]
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